The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The Italian Association for the Study and Control of Contamination (ASCCA), in collaboration with the International Confederation of Contamination Control Societies...
US industrial gases producer Air Products has agreed to acquire Saneg’s hydrogen production assets at the Fergana oil refinery in Uzbekistan for $140 million.
In order to meet significantly higher demand from its parent company Novo Nordisk, Novo Nordisk Pharmatech is planning to build a new factory at a 47,000 m² site in Køge...
Brenntag has acquired PIC Química e Farmacêutica and PharmaSpecial Especialidades Químicas e Farmacêuticas in Brazil. This acquisition significantly expands the company’s...
A recent report by consulting company WittKiefer delves into the role of CDMOs within the pharmaceutical industry, evaluating the effectiveness of existing leadership...
